NERV Minerva Neurosciences, Inc.
Healthcare$5.22-0.76%ClosedMarket Cap: $36.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.91
P/S
0.00
EV/EBITDA
-0.23
DCF Value
$1.98
FCF Yield
-14779.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
359.8%
ROA
-441.4%
ROIC
-31.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-16.7M | $-125.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-5.0M | $-283.7M | $— | — |
| FY null | $0.00 | NaN% | $-15.1M | $-293.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.8M | $-2.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.4M | $-3.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.9M | $-3.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.5M | $-4.3M | $— | — |
| FY null | $0.00 | NaN% | $-21.8M | $1.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.4M | $22.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.3M | $-8.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.7M | $-8.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-7.2M | $-9.0M | $-1.19 | — |